These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 4889322)

  • 1. The use of plasma fractions in the treatment of hemophilia and von Willebrand's disease.
    Rizza CR; Biggs R
    Prog Hematol; 1969; 6():181-200. PubMed ID: 4889322
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemophilia and von Willebrand's disease: 1. Diagnosis, comprehensive care and assessment. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(1):19-25. PubMed ID: 7796372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of plasma and/or factor VIII concentrates administration on platelet functions in patients with haemophilia A and von Willebrand's disease (author's transl)].
    Gamba G; Grignani G; Nicolini E; Ascari E
    Haematologica; 1975 Jun; 60(2):168-83. PubMed ID: 808449
    [No Abstract]   [Full Text] [Related]  

  • 5. Progress and problems in hemophilia and von Willebrand's disease.
    Abildgaard CF
    Adv Pediatr; 1984; 31():137-77. PubMed ID: 6440429
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathogenesis and treatment of Willebrand's disease].
    Meili EO; Straub PW; Frick PG
    Schweiz Med Wochenschr; 1969 Dec; 99(50):1805-10. PubMed ID: 5311783
    [No Abstract]   [Full Text] [Related]  

  • 7. A 1973 look at hemophilia and von Willebrand's disease.
    Ratnoff OD
    Proc Inst Med Chic; 1973; 29(9):296-304. PubMed ID: 4581203
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of von Willebrand's Disease.
    Mannucci PM
    N Engl J Med; 2004 Aug; 351(7):683-94. PubMed ID: 15306670
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease].
    Fukui H; Takase T
    Rinsho Ketsueki; 1985 Jul; 26(7):1069-79. PubMed ID: 3932720
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical aspects of hemophilia and von Willebrand's disease.
    Ciavarella D; Counts RB
    Am J Med Technol; 1983 Dec; 49(12):850-4. PubMed ID: 6422754
    [No Abstract]   [Full Text] [Related]  

  • 11. [Factor VIII in hemophilia and von Willebrand's disease].
    Bolland J; Lambotte C
    Rev Med Liege; 1978 Apr; 33(8):284-95. PubMed ID: 349657
    [No Abstract]   [Full Text] [Related]  

  • 12. Correction by factor VIII of decreased neutrophil alkaline phosphatase activity in classic haemophilia and von Willebrand's disease.
    Janković GM; Janosević S
    Haematologia (Budap); 1978-1979; 12(1-4):183-8. PubMed ID: 317061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of circulating immune complexes on transfusional therapy in patients with hemophilia or von Willebrand's disease.
    Celada A; Aguado MT; Maire M; Ortega F; Magallon M; Martin-Villar J; Lambert PH
    Transfusion; 1984; 24(1):46-52. PubMed ID: 6420954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with factor VIII: C inhibitors and acquired von Willebrand's disease in an adult at Ramathibodi Hospital.
    Angchaisuksiri P; Atichartakarn V; Pathepchotiwong K; Jootar S; Ungkanont A; Chuncharunee S
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():152-8. PubMed ID: 7886560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of human viral disease transmission through plasma products.
    Heldebrant CM; Friedman AE; Fedor EJ
    Dev Biol Stand; 1987; 67():319-22. PubMed ID: 2440744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of von Willebrand's disease].
    Rafanelli D; Vannucchi AM; Morfini M
    G Clin Med; 1988 Jan; 69(1):63-6. PubMed ID: 3133271
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of hemophilias].
    Fischer M; Deutsch E
    Dtsch Med J; 1968 Jul; 19(14):499-505. PubMed ID: 5305713
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of the hereditary coagulation disorders.
    Mason DY; Ingram GI
    Semin Hematol; 1971 Apr; 8(2):158-88. PubMed ID: 5313347
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemophilia in Sweden. Studies on demography of hemophilia and surgery in hemophilia and von Willebrand's disease.
    Larsson SA
    Acta Med Scand Suppl; 1984; 684():1-72. PubMed ID: 6611018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of anti-human immunodeficiency virus types 1 and 2 seroconversion after the treatment of hemophilia A or von Willebrand's disease with pasteurized factor VIII concentrate.
    Schimpf K; Brackmann HH; Kreuz W; Kraus B; Haschke F; Schramm W; Moesseler J; Auerswald G; Sutor AH; Koehler K
    N Engl J Med; 1989 Oct; 321(17):1148-52. PubMed ID: 2507917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.